Saturday 5 April 2003 | ||
Organizers | K. Mašek (Prague, Tsjech Republic) J.W. Hadden (Tampa, USA) |
|
Sponsor | ISIP (International Society of Immunopharmacology), Tsjech Republic | |
Immunopharmacology: from laboratory bench to clinical practice |
||
Session I | ||
Chair | K. Mašek (Prague, Tsjech Republic) | Abstract No. |
09.40 – 10.10 | Combination immunotherapy of cancer J.W. Hadden (Tampa, USA) |
|
10.10 – 10.40 | Neuroendocrine immune interactions in health and disease K. Mašek, J.W. Hadden (Prague, Tsjech Republic/Tampa, USA) |
|
10.40 – 11.00 | Discussion | |
11.00 – 11.15 | coffee break | |
11.15 – 11.45 | Vaccine engineering for Th1 responses F. Audibert (Paris, France) |
|
11.45 – 12.15 | The immunopharmacology of infectious diseases K.N. Masihi (Berlin, Germany) |
|
12.15 – 12.30 | The imidazoquinoline R-848 shifts human allergen-specific Th2 cells into Th1 effectors F. Brugnolo, L. Filì, S. Sampognaro, L. Cosmi, F. Liotta, F. Annunziato, C. Manuelli, E. Maggi, S. Romagnani, and P. Parronchi (Florence, Italy) |
159 |
12.30 – 12.45 | In vitro testing for immunomodulatory capacity of red and white wines G. Neurauter, B. Wirleitner, K. Schroecksnadel and D. Fuchs (Innsbruck, Austria) |
160 |
12.45 – 13.00 | Discussion | |
13.00 | End of workshop | |
Posters
161
AFP-receptor – the universal target for targeted drug delivery
S. Severin, M. Nitsvetov, E. Moskaleva, A. Rodina, O. Makarova., V. Stepanov, Yu. Belousova, G. Posypanova, A. Karaulov, and E. Severin (Moscow, Russia)
162
Treatable effect of Plaferon LB on ConA induced hepatitis
M.A. Kvezereli, T.I. Chikovani, and T. Sanikidze (Tbilisi, Georgia(NIS))